## List 10 (34 Maturity Indicators)

RiskGONE toxicity risk assessment quality measures (in vivo/in vitro)

## Reference Publication

**Title:** RiskGONE toxicity risk assessment quality measures

**Reference Website:** https://riskgone.eu

* **DOI SHA256:** 57299b68d49654e043836acfbacaeff76900994227c8dcba53f4f04252f30978
* **Truncated SHA256 (Used as List ID):** 57299b68d4

Each list of maturity indicators is identified with 10-characters string which is truncated from the SHA256 hash of their reference publication DOI.

--------------------

### Maturity indicators in this list:

1. The dose/concentration is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_DOSE.md)
1. The exposure duration/time-points of observation are is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_EXPOSURE_DURATION.md)
1. The determination methods of the study endpoints are reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_DETERMINATION_METHODS.md)
1. The negative controls are reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_NEGATIVE_CONTROLS.md)
1. The test substance physiochemical characterization is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_SUBSTANCE_CHARACTERIZATION.md)
1. The test substance source is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_SUBSTANCE_SOURCE.md)
1. The results of the study endpoints are all reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_ENDPOINT_RESULTS.md)
1. The exposure duration/time-points of observation are is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_EXPOSURE_DURATION.md)
1. The statistical methods for data analysis are reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_STATISTICAL_METHODS.md)
1. The test substance purity is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_SUBSTANCE_PURITY.md)
1. The test substance purity is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_SUBSTANCE_PURITY.md)
1. The negative controls are reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_NEGATIVE_CONTROLS.md)
1. The administration method is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_ADMINISTRATION_METHOD.md)
1. The dose/concentration is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_DOSE.md)
1. The test substance identity is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_SUBSTANCE_IDINTITY.md)
1. The administration method is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_ADMINISTRATION_METHOD.md)
1. The statistical methods for data analysis are reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_STATISTICAL_METHODS.md)
1. The determination methods of the study endpoints are reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_DETERMINATION_METHODS.md)
1. The test substance physiochemical characterization is reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_SUBSTANCE_CHARACTERIZATION.md)
1. The results of the study endpoints are all reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_ENDPOINT_RESULTS.md)
1. The test substance identity is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_SUBSTANCE_IDINTITY.md)
1. The test substance source is reported by the nano toxicity study (in vivo) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VIVO_SUBSTANCE_SOURCE.md)
1. The positive controls are reported by the nano toxicity study (in vitro) [link](https://github.com/ammar257ammar/NanoMaturityIndicators/blob/main/10-57299b68d4/MI-R1.3-57299b68d4-IN_VITRO_POSITIVE_CONTROLS.md)
